Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Theravance Biopharma, Inc.TBPH · Entity 5037 | SVP, TECHNICAL OPERATIONS | November 19, 2021 | November 24, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Theravance Biopharma, Inc.
Report date November 19, 2021 · Filed November 24, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 235,524 |
Reported balance
After 2021-11-19 transaction · row 1
1 source rowRow 1 · 2021-11-19 · Tax withholding · Disposed 5,191 · Balance 235,524 F1: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2021 Filed Nov 24, 2021 01:21 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 5,191 | $8.36 | $43,396.76 |
DisclosureSEC source: 0001415889-21-005464 · form4-11232021_051139.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, TECHNICAL OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,524 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:01 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 5,193 | $14.05 | $72,961.65 |
DisclosureSEC source: 0001179110-21-008400 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,715 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| May 20, 2021 Filed May 24, 2021 22:16 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 5,194 | $17.80 | $92,453.20 |
DisclosureSEC source: 0001179110-21-005848 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,908 F1 · balance_after: Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 23:13 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 8,343 | $18.79 | $156,764.97 |
DisclosureSEC source: 0001179110-21-002171 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,701 Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:48 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | GrantOrdinary Shares | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001539 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,044 Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:21 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 3,798 | $17.21 | $65,363.58 |
DisclosureSEC source: 0001179110-20-011373 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,044 Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 22:32 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 3,799 | $18.22 | $69,217.78 |
DisclosureSEC source: 0001179110-20-009271 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,842 Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:10 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 3,801 | $26.67 | $101,372.67 |
DisclosureSEC source: 0001179110-20-006530 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,641 F1 · balance_after: Includes 1,402 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2020. Read SEC document |
| February 20, 2020 Filed Feb 25, 2020 00:12 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 7,213 | $25.90 | $186,816.70 |
DisclosureSEC source: 0001179110-20-002152 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,040 Read SEC document |
| February 03, 2020 Filed Feb 6, 2020 00:04 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | GrantOrdinary Shares | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001206 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,253 Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 23:09 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | SaleOrdinary Shares | 1,027 | $21.03 | $21,597.91 |
DisclosureSEC source: 0001179110-19-012848 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,253 Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 23:24 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 1,473 | $17.60 | $25,924.80 |
DisclosureSEC source: 0001179110-19-012019 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,280 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 22:05 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 1,472 | $21.51 | $31,662.72 |
DisclosureSEC source: 0001179110-19-009794 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,753 Read SEC document |
| May 20, 2019 Filed May 22, 2019 22:13 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 1,474 | $19.84 | $29,244.16 |
DisclosureSEC source: 0001179110-19-006530 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,225 F1 · balance_after: Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 23:20 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | Tax withholdingOrdinary Shares | 4,568 | $27.00 | $123,336.00 |
DisclosureSEC source: 0001179110-19-002427 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,672 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.